News from agendia A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 05, 2020, 07:00 ET Agendia to Participate in 2020 Canaccord Genuity Virtual MedTech & Diagnostics Forum

Agendia, Inc., a world leader in precision oncology for breast cancer, today announced its participation in the 2020 Canaccord Genuity Virtual...

Oct 28, 2020, 07:00 ET Agendia Co-Founder Named to Eighth Annual OncLive® Giants of Cancer Care® Class of Inductees

Agendia, Inc., a world leader in precision oncology for breast cancer, today announced that co-founder and Chief Research Officer Laura van 't Veer,...

Oct 21, 2020, 02:00 ET MammaPrint® Approved for Reimbursement in Germany

Agendia Inc., a world leader in precision oncology for breast cancer, announced today that the Federal Joint Committee (G-BA) has approved...

Oct 15, 2020, 10:45 ET Agendia to Participate in Stifel 2020 Virtual Healthcare Conference

Agendia, Inc., a world leader in precision oncology for breast cancer, today announced its participation in the 2020 Stifel Virtual Healthcare...

Oct 02, 2020, 18:18 ET Agendia Presents New Data Demonstrating Clinical Utility for MammaPrint and BluePrint at the 2020 European Breast Cancer Conference Virtual Event

Agendia, Inc., a world leader in precision oncology for breast cancer, today announced the presentation of four studies at the 12th European Breast...

Oct 01, 2020, 09:00 ET Agendia Celebrates Breast Cancer Awareness Month with Digital Art Installation

In celebration of Breast Cancer Awareness Month, Agendia, Inc., a world leader in precision oncology for breast cancer, is proud to present the I AM...

Sep 17, 2020, 03:01 ET Agendia Presents New Data Demonstrating MammaPrint's Clinical Utility in Treatment Decisions for Ultra-Low Risk Breast Cancer Patients at the European Society for Medical Oncology Virtual Congress

Agendia, Inc., a world leader in precision oncology for breast cancer, today presented data at the European Society for Medical Oncology (ESMO)...

Sep 14, 2020, 08:00 ET Agendia to Showcase New Data at the European Society for Medical Oncology Virtual Congress 2020

IRVINE, Calif., Sept. 14, 2020 /CNW/ - Agendia, Inc. a world leader in precision oncology for breast cancer today announced that new clinical data...

Aug 25, 2020, 07:00 ET MINDACT Study Shows MammaPrint® Provides Widespread Health System Cost Savings

Agendia, Inc., a world leader in precision oncology for breast cancer, announced the publication of multi-country cost analyses from the landmark...

Aug 14, 2020, 08:00 ET Inc. Magazine Unveils Its Annual List of America's Fastest-Growing Private Companies--the Inc. 5000

This week, Inc. magazine revealed that Agendia, Inc. has been included on its annual Inc. 5000 list, the most prestigious ranking of the nation's...

Jul 29, 2020, 08:00 ET Agendia Expands Management Team to Meet Company Momentum, Appoints Brian Dow as Chief Financial Officer

Agendia, Inc., a world leader in precision oncology for breast cancer, today announced the appointment of Brian Dow as Chief Financial Officer in the ...

Jul 27, 2020, 05:12 ET Agendia Publishes Unprecedented Full Genome Dataset from MINDACT Trial for the Advancement of Translational Research in Communications Biology

Agendia, Inc., a world leader in precision oncology for breast cancer, today announced the publication of MINDACT trial data in the July 27 issue of...

May 29, 2020, 08:00 ET Agendia Announces Data Presented at ASCO 2020 Demonstrating Importance of Further Classification of Breast Cancers to Enable Precise Prognosis and Treatment

Agendia, Inc., a world leader in precision oncology for breast cancer, announced that new data from ongoing clinical research on MammaPrint® and...

May 29, 2020, 08:00 ET Long-Term Follow Up Data from Groundbreaking MINDACT Study Continues to Demonstrate Clinical Utility of MammaPrint™

Agendia, Inc., a world leader in precision oncology for breast cancer, today announced new data from MINDACT, the prospective randomized trial...

May 14, 2020, 08:00 ET Agendia to Showcase New Data at ASCO 2020 That Further Stratifies Breast Cancer Patients for More Precise Therapy Recommendations

Agendia, Inc., a world leader in precision oncology for breast cancer, announced today that they will present new data from its ongoing clinical...

May 07, 2020, 11:30 ET Agendia Co-Founder and Chief Scientific Officer René Bernards, PhD Elected to the National Academy of Sciences

Agendia, Inc., a world leader in precision oncology for breast cancer, today announced that the Company's Co-Founder and Chief Scientific Officer, Dr....

Apr 16, 2020, 09:00 ET Long Term Analytical Validation Study Further Confirms BluePrint as a Reliable Genomic Profiling Assay for Early Stage Breast Cancer Patients

Agendia®, Inc., a world leader in precision oncology for breast cancer, announced today that Translational Cancer published long term analytical...

Feb 18, 2020, 11:52 ET Results from the IMPACt Trial Show Agendia Assays Consistently Inform Treatment Planning and Increase Physician Confidence when Caring for Patients with Early Stage Breast Cancer

Agendia, Inc., a world leader in precision oncology for breast cancer, announced today that BMC Cancer published results from the IMPACt trial. The...

Jan 17, 2020, 09:00 ET Laura van 't Veer, PhD, Co-Inventor of MammaPrint, Honored with the PMWC Luminary Award at Precision Medicine World Conference 2020

Laura van 't Veer, Ph.D., co-founder of Agendia Inc. and developer of MammaPrint, the 70-gene risk of recurrence assay for breast cancer patients,...

Jan 03, 2020, 06:00 ET Breast Cancer Patients in Germany Now have Insurance Coverage for MammaPrint® Testing through Techniker Krankenkasse

Agendia Inc., a world leader in precision oncology for breast cancer, announces that one of the largest healthcare insurers in Germany, Techniker...

Dec 12, 2019, 08:01 ET New Data Compare Genomic Profiling Results for Premenopausal Women with Early-Stage Breast Cancer

Agendia, Inc., a world leader in precision oncology for breast cancer, announced today new data comparing genomic profiling results for patients...

Nov 19, 2019, 09:30 ET Agendia to Present New Data at SABCS 2019 Demonstrating How Comprehensive Genomic Profiling Benefits Early-Stage Breast Cancer Patients

Agendia, Inc., a world leader in precision oncology for breast cancer, announced today that five abstracts featuring data and updates from its...

Sep 09, 2013, 02:29 ET Multiple International Breast Cancer Guidelines Confirm Use of Agendia Tests for Prognostic, Predictive Information in Cancer Treatment Decisions

Agendia, a leader in molecular cancer diagnostics, today announced that multiple established international breast cancer treatment guidelines...

Aug 27, 2013, 06:00 ET Researchers Identify Splice Variant of Breast Cancer Gene that Can Mask Risk of Recurrence

Agendia, a leader in molecular cancer diagnostics, announced today that researchers have identified a subset of breast cancer patients whose standard ...

Jun 03, 2013, 10:00 ET Agendia Appoints Peter W. Schineller as Chief Commercial Officer

Agendia, a leader in molecular cancer diagnostics, today announced the addition of Peter W. Schineller as its Chief Commercial Officer. In this newly ...